Finding 366475 (2021-003)

Material Weakness Repeat Finding
Requirement
I
Questioned Costs
-
Year
2021
Accepted
2024-02-07

AI Summary

  • Core Issue: UHU failed to consistently screen vendors and contractors for federal funding compliance, risking payments to excluded parties.
  • Impacted Requirements: Federal guidelines mandate documented screenings of all parties involved with federal funds to avoid business with suspended or debarred entities.
  • Recommended Follow-Up: UHU should implement formal screening policies, educate staff, document screenings, and conduct annual checks to ensure ongoing compliance.

Finding Text

Information on Federal Program: Assistance Listing Numbers 93.914 and 93.917 Criteria or Specific Requirement: Recipients of Federal funding must adhere to specific requirements on screening of all potential and current vendors, suppliers, contractors, subrecipients, employees, fellows, etc. to ensure the recipient is not conducting business with excluded parties (as defined by the United States Government). This screening process must also be documented in writing. Condition: UHU did not consistently perform the screening process for its potential and current vendors, suppliers, contractors, subrecipients, employees, etc. that were paid with Federal funds. Context: Payments were made during the fiscal year without performing the proper screening process. Our audit work in this area consisted of internal control testwork over a random sample of expenditures, as well as substantive testwork over transactions above a defined threshold from select expense accounts that were charged to the Federal program. The issue is deemed to be systemic. Cause: UHU did not have a formal policy in place with regard to suspension and debarment screenings, although they did occasionally perform screening of potential and current vendors, suppliers, contractors, subrecipients, and employees. Effect or Potential Effect: Failure to screen potential and current vendors, suppliers, contractors, subrecipients, employees, fellows, etc. increases the potential that Federal funds be inadvertently provided to parties deemed to be suspended or disbarred by the United States Government. Questioned Costs: Undetermined Identification of Repeat Finding: 2020-005 Recommendation: We recommend UHU establish policies and ensure that all types of parties (as noted above) are included, and educate its employees on the procedures necessary to ensure full compliance with this requirement. We also recommend that UHU document each of these screenings and retain them in the respective files, which should be completed prior to engaging in relationships with these parties. For ongoing relationships, UHU should consider performing screenings on an annual basis (and documenting them) to ensure continuous compliance in the event the suspension and debarment status of any of these parties changes. Lastly, we recommend UHU perform retrospective screenings on these parties to which it made payments during the fiscal year.

Categories

Procurement, Suspension & Debarment Subrecipient Monitoring

Other Findings in this Audit

  • 366445 2021-001
    Material Weakness Repeat
  • 366446 2021-002
    Material Weakness Repeat
  • 366447 2021-003
    Material Weakness Repeat
  • 366448 2021-004
    Material Weakness Repeat
  • 366449 2021-005
    Material Weakness Repeat
  • 366450 2021-006
    Material Weakness Repeat
  • 366451 2021-007
    Material Weakness Repeat
  • 366452 2021-001
    Material Weakness Repeat
  • 366453 2021-002
    Material Weakness Repeat
  • 366454 2021-003
    Material Weakness Repeat
  • 366455 2021-004
    Material Weakness Repeat
  • 366456 2021-005
    Material Weakness Repeat
  • 366457 2021-006
    Material Weakness Repeat
  • 366458 2021-007
    Material Weakness Repeat
  • 366459 2021-001
    Material Weakness Repeat
  • 366460 2021-002
    Material Weakness Repeat
  • 366461 2021-003
    Material Weakness Repeat
  • 366462 2021-004
    Material Weakness Repeat
  • 366463 2021-005
    Material Weakness Repeat
  • 366464 2021-006
    Material Weakness Repeat
  • 366465 2021-007
    Material Weakness Repeat
  • 366466 2021-001
    Material Weakness Repeat
  • 366467 2021-002
    Material Weakness Repeat
  • 366468 2021-003
    Material Weakness Repeat
  • 366469 2021-004
    Material Weakness Repeat
  • 366470 2021-005
    Material Weakness Repeat
  • 366471 2021-006
    Material Weakness Repeat
  • 366472 2021-007
    Material Weakness Repeat
  • 366473 2021-001
    Material Weakness Repeat
  • 366474 2021-002
    Material Weakness Repeat
  • 366476 2021-004
    Material Weakness Repeat
  • 366477 2021-005
    Material Weakness Repeat
  • 366478 2021-006
    Material Weakness Repeat
  • 366479 2021-007
    Material Weakness Repeat
  • 366480 2021-001
    Material Weakness Repeat
  • 366481 2021-002
    Material Weakness Repeat
  • 366482 2021-003
    Material Weakness Repeat
  • 366483 2021-004
    Material Weakness Repeat
  • 366484 2021-005
    Material Weakness Repeat
  • 366485 2021-006
    Material Weakness Repeat
  • 366486 2021-007
    Material Weakness Repeat
  • 942887 2021-001
    Material Weakness Repeat
  • 942888 2021-002
    Material Weakness Repeat
  • 942889 2021-003
    Material Weakness Repeat
  • 942890 2021-004
    Material Weakness Repeat
  • 942891 2021-005
    Material Weakness Repeat
  • 942892 2021-006
    Material Weakness Repeat
  • 942893 2021-007
    Material Weakness Repeat
  • 942894 2021-001
    Material Weakness Repeat
  • 942895 2021-002
    Material Weakness Repeat
  • 942896 2021-003
    Material Weakness Repeat
  • 942897 2021-004
    Material Weakness Repeat
  • 942898 2021-005
    Material Weakness Repeat
  • 942899 2021-006
    Material Weakness Repeat
  • 942900 2021-007
    Material Weakness Repeat
  • 942901 2021-001
    Material Weakness Repeat
  • 942902 2021-002
    Material Weakness Repeat
  • 942903 2021-003
    Material Weakness Repeat
  • 942904 2021-004
    Material Weakness Repeat
  • 942905 2021-005
    Material Weakness Repeat
  • 942906 2021-006
    Material Weakness Repeat
  • 942907 2021-007
    Material Weakness Repeat
  • 942908 2021-001
    Material Weakness Repeat
  • 942909 2021-002
    Material Weakness Repeat
  • 942910 2021-003
    Material Weakness Repeat
  • 942911 2021-004
    Material Weakness Repeat
  • 942912 2021-005
    Material Weakness Repeat
  • 942913 2021-006
    Material Weakness Repeat
  • 942914 2021-007
    Material Weakness Repeat
  • 942915 2021-001
    Material Weakness Repeat
  • 942916 2021-002
    Material Weakness Repeat
  • 942917 2021-003
    Material Weakness Repeat
  • 942918 2021-004
    Material Weakness Repeat
  • 942919 2021-005
    Material Weakness Repeat
  • 942920 2021-006
    Material Weakness Repeat
  • 942921 2021-007
    Material Weakness Repeat
  • 942922 2021-001
    Material Weakness Repeat
  • 942923 2021-002
    Material Weakness Repeat
  • 942924 2021-003
    Material Weakness Repeat
  • 942925 2021-004
    Material Weakness Repeat
  • 942926 2021-005
    Material Weakness Repeat
  • 942927 2021-006
    Material Weakness Repeat
  • 942928 2021-007
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.939 Hiv Prevention Activities_non-Governmental Organization Based $309,237
93.136 Injury Prevention and Control Research and State and Community Based Programs $207,309
93.917 Hiv Care Formula Grants $199,583
19.029 The U.s. President's Emergency Plan for Aids Relief Programs $150,000
93.940 Hiv Prevention Activities_health Department Based $59,756
93.279 Drug Abuse and Addiction Research Programs $38,859
93.914 Hiv Emergency Relief Project Grants $500